● Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Condition: Chronic Inducible Urticaria · Cold Urticaria · Cold-Induced Urticaria · Sponsor: Celldex Therapeutics

PhasePhase 3

Planned participants240

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or symptomatic dermographism who remain symptomatic despite the use of H1-antihistamines.

This description comes directly from the study's public registry record.

Talk to the study team

Celldex Therapeutics · 844-723-9363 · clinicaltrials@celldex.com

Always discuss trial participation with your own doctor first.

Locations (73)

Cahaba Dermatology & Skin Health Center, LLC	Birmingham, Alabama, United States	Recruiting
One of a Kind Clinical Research Center, LLC	Scottsdale, Arizona, United States	Recruiting
Kern Research, Inc.	Bakersfield, California, United States	Recruiting
One of a Kind Clinical Research Center	Napa, California, United States	Recruiting
Allergy & Asthma Consultants	Redwood City, California, United States	Recruiting
Amicis Research Center	Sherman Oaks, California, United States	Recruiting
FOMAT - Allergy, Asthma & Immunology Medical Group	Ventura, California, United States	Recruiting
Direct Helpers Research Center	Hialeah, Florida, United States	Recruiting
Well Pharma Medical Research, Corp.	Miami, Florida, United States	Recruiting
Deluxe Health Center, LLC	Miami Lakes, Florida, United States	Recruiting
GCP, Global Clinical Professionals	St. Petersburg, Florida, United States	Recruiting
Advanced Clinical Research Institute	Tampa, Florida, United States	Recruiting

+ 61 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07266402